A practical reference on PPARδ agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-11 and is reviewed periodically as new material appears.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a PPARδ agonist. |
| Typical detection matrix | Urine | Most common sample for anti-doping analysis. |
| Common analytical method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry. |
| Common synonyms | GW501516, GSK-516, endurobol | Names found in research and fitness contexts. |
| Typical detection window | Variable | Depends on dose, route, and individual metabolism. |
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
In August 2008, Eli Lilly purchased the right to manufacture bovine somatotropin (bovine growth hormone), used to increase milk production in dairy cattle, from Monsanto. Use of the supplement has become controversial due to the animal ethics and human health concerns.
The royal angelfish (Pygoplites diacanthus), or regal angelfish, is a species of marine ray-finned fish, a marine angelfish belonging to the family Pomacanthidae, and the monotypic genus Pygoplites. It is found in tropical Indo-Pacific oceans. It can grow as long as 25 cm (9.8 in).
The island chain is a western continuation of the Aleutian Range on the mainland. The great majority of the islands bear evident marks of volcanic origin, and there are numerous volcanic cones on the north side of the chain, some of them active; many of the islands, however, are not wholly volcanic, but contain crystalline or sedimentary rocks, and also amber and beds of lignite. The coasts are rocky and surf-worn, and the approaches are exceedingly dangerous, the land rising immediately from the coasts to steep, bold mountains. These volcanic islands reach heights of 6,200 feet (1,900 m). Makushin Volcano (5,691 feet (1,735 m)) on Unalaska Island, is not quite visible from within the town of Unalaska, though the steam rising from its cone is visible on a (rare) clear day. Residents of Unalaska need only to climb one of the smaller hills in the area, such as Pyramid Peak or Mt. Newhall, to get a good look at the snow-covered cone. The volcanic Bogoslof and Fire Islands, which rose from the sea in 1796 and 1883 respectively, lie about 30 miles (50 km) west of Unalaska Bay. In 1906, a new volcanic cone rose between the islets of Bogoslof and Grewingk, near Unalaska, followed by another in 1907. These cones were nearly demolished by an explosive eruption on September 1, 1907. In 2017, the volcanic cone erupted sending ash and ice particles 30,000 feet (9000 m) into the air.
=== Non refractive roles of crystallins in lens and cornea === While it is evident that gene sharing resulted in many of lens crystallins being multifunctional proteins, it is still uncertain to what extent the crystallins use their non-refractive properties in the lens, or on what basis they were selected. The α-crystallins provide a convincing case for a lens crystallin using its non-refractive ability within the lens to prevent protein aggregation under a variety of environmental stresses and to protect against enzyme inactivation by post-translational modifications such as glycation. The α-crystallins may also play a functional role in the stability and remodeling of the cytoskeleton during fiber cell differentiation in the lens. In cornea, ALDH3 is also suggested to be responsible for absorbing UV-B light.
The following day, Lee insisted that Peart's remarks had been taken out of context, and suggested he was "simply taking a break". Lifeson confirmed in 2016 that the R40 tour was the band's last large-scale tour. A documentary, Time Stand Still, was announced in November 2016. On January 16, 2018, Lifeson told The Globe and Mail that it was unlikely that Rush would play any more shows or record new material. He said, "We have no plans to tour or record anymore. We're basically done. After 41 years, we felt it was enough." In October 2018, Rolling Stone published an interview with Lee, who said:
Sources: en.wikipedia.org
=== Disorders of carbohydrate transport and metabolism === 271 Disorders of carbohydrate transport and metabolism 271.0 Glycogenosis Von Gierke's disease McArdle's disease Pompe's disease 271.1 Galactosemia 271.2 Hereditary fructose intolerance 271.3 Intestinal disaccharidase deficiencies and disaccharide malabsorption Lactose intolerance Glucose intolerance 271.4 Renal glycosuria 271.8 Other specified disorders of carbohydrate transport and metabolism 271.9 Unspecified disorder of carbohydrate transport and metabolism
== Drug liberalization == Drug liberalization as a harm-reduction strategy gives the ability to treat substance use disorder solely as a public health issue rather than a criminal activity. This enables other harm-reduction strategies to be employed, which results in a lower incidence of HIV infection.
=== Veterinary === Heinz bodies are associated with the consumption of paracetamol (acetaminophen), garlic, and onions by cats, dogs, and various primates. Thiosulfate compounds in the flesh of onions have been identified as the cause. Propylene glycol was once a common ingredient in soft moist cat food. According to the FDA "It was known for some time that propylene glycol caused Heinz Body formation in the red blood cells of cats (small clumps of proteins seen in the cells when viewed under the microscope), but it could not be shown to cause overt anemia or other clinical effects. However, recent reports in the veterinary literature of scientifically sound studies have shown that propylene glycol reduces the red blood cell survival time, renders red blood cells more susceptible to oxidative damage, and has other adverse effects in cats consuming the substance at levels found in soft-moist food. In light of this new data, CVM amended the regulations to expressly prohibit the use of propylene glycol in cat foods."
Day of Defeat is a class-based multiplayer first-person shooter video game set in the European theatre of World War II on the Western front. Originally a modification of the 1998 game Half-Life, the rights of the modification were purchased by Valve and released as a full retail title in 2003. Set in the midst of World War II, Day of Defeat includes no single-player campaign, with focus left only on the game's multiplayer aspects. The game favors teamwork and features objective-based gameplay in combination with its system of classes. Maps are primarily made up of narrow paths, all of which typically lead to a few key locations. An official remake of the game, Day of Defeat: Source, was released by Valve in 2005.
Methyl jasmonate is volatile and can therefore activate systemic acquired resistance in neighbouring plants, preparing their defences for attack. These signalling events are analogous to the cytokine-mediated inflammatory immune response in animals. When the inflammatory response is activated in animals, MAPKs are activated which in turn activate phospholipases. Lipids in the membrane are converted to arachidonic acid and then to prostaglandins, which are analogs of jasmonic acid. Both pathways can be inhibited by suramin. Early experiments with radiolabelled systemin in tomato demonstrated that it is transported through the phloem sap in tomato plants and was therefore thought to be the systemic signal that activated systemic acquired resistance. This view was challenged by grafting experiments which showed that mutants deficient in jasmonic acid biosynthesis and perception were unable to activate systemic acquired resistance. It is now thought that jasmonic acid is the systemic signal and that systemin upregulates the pathways for jasmonic acid synthesis.
Sources: en.wikipedia.org
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.
Detection usually uses liquid chromatography-tandem mass spectrometry after sample cleanup. Laboratories look for the parent compound or metabolites. The method requires validated reference standards and controls.
Legality varies by country. In many places it is an unapproved drug and cannot be legally sold for human consumption. Purchasing from online vendors carries legal and quality risks.
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.